BMJ Rapid Recommendations: A Possible Revolution in Clinical Practice Guidelines

Guyatt, Gordon; Agoritsas, Thomas; Lytvyn, Lyubov; Siemieniuk, Reed A C; Vandvik, Per Olav

doi:10.22374/cjgim.v14i1.318

Cited by 10 publications

(5 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To ensure that the content of guidelines is consistent with the current best evidence, guidelines should be updated 4,34 with the emergence of new evidence that might change the TDM practice and management, 33 generally every 2–5 years 35–38 . The guideline updates should prioritize controversial areas or new evidence fields that have an impact on the recommendations 35,36 .…”

Section: The Development Processes and Methods Of Tdm Guidelinesmentioning

confidence: 99%

The guideline for therapeutic drug monitoring guidelines development

Zeng

Huang

et al. 2022

J Evidence Based Medicine

View full text Add to dashboard Cite

Aim The guideline is meant to standardize the principles, procedures, and methods for developing therapeutic drug monitoring (TDM) guidelines and promoting open, transparent, scientific, and credible TDM guidelines. Methods Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society established guideline working groups, declared and managed conflicts of interest. The guideline working groups used the Delphi method to formulate the purpose and scope of the guidelines and questions in the PICO format, searched and synthesized evidence, and integrated with the current situation in China and TDM characteristics to preliminarily develop recommendations for the guideline for TDM guideline development in China. Through internal discussions of the guideline working groups and external peer review, the content was improved, and we eventually formulated a guideline suitable for guiding TDM‐related guidelines. Results The guideline provides suggestions for problems to be identified and solved in the planning, development, publishing, and updating stages of TDM guidelines, including forming guideline working groups, planning guidelines, declaration and management of interests, formulating questions and selecting outcomes, preparing the planning proposal, evidence retrieval and synthesis, evidence assessment, developing recommendations, drafting guidelines, external review guidelines, publishing and disseminating guidelines, postevaluation of guidelines, and updating guidelines. Conclusions This guideline can provide methodological guidance and reference for the development of TDM guidelines.

show abstract

Section: The Development Processes and Methods Of Tdm Guidelinesmentioning

confidence: 99%

The guideline for therapeutic drug monitoring guidelines development

Zeng

Huang

et al. 2022

J Evidence Based Medicine

View full text Add to dashboard Cite

show abstract

“…The strengths and limitations of rapid guidelines have been previously reported (19)(20)(21). The merits of rapid guidelines, including trustworthiness, credibility, and time efficiency have to outweigh the shortcomings, such as the narrow scope and possible missing of resources due to the rapid review process.…”

Section: Strengths and Limitationsmentioning

confidence: 99%

Protocol for EHS Rapid Guideline: Systematic Review, Meta-Analysis, GRADE Assessment, and European Recommendations on Parastomal Hernia Prevention

Antoniou

Stabilini

Koutsiouroumpa³

et al. 2022

J. Abdom. Wall Surg.

View full text Add to dashboard Cite

Background: Parastomal hernia presents frequently after construction of a permanent end colostomy. Previous guidelines recommend using a prophylactic mesh for hernia prevention. Randomized controlled trials (RCTs) published hereafter demonstrate conflicting outcomes.Methods and Analysis: A rapid guideline will be developed and reported in accordance with GRADE, GIN and AGREE-S standards. The steering group will consist of general and colorectal surgeons, members of the EHS Scientific Advisory Board with expertise and experience in guideline development, advanced medical statistics and evidence synthesis, and a certified guideline methodologist. The guideline panel will consist of three general surgeons, three colorectal surgeons, two stoma care nurses, and two patient representatives. A single question will address the safety and efficacy of the use of a prophylactic mesh in patients with a permanent end colostomy, and sensitivity analyses will focus on the use of non-absorbable versus absorbable meshes, and on different anatomical spaces for mesh placement. A systematic review will be conducted and evidence synthesis will be performed by statisticians independently. The results of evidence synthesis will be summarized in summary of findings tables. Recommendation(s) will be finalized through Delphi process of the guideline panel within an evidence-to-decision framework.Ethics and Dissemination: The funding body will not be involved in the development of this guideline. Conflicts of interest, if any, will be addressed by re-assigning functions or replacing participants with direct conflicts, according to Guidelines International Network recommendations.

show abstract

“…The process is further simplified by designating the two levels of recommendations, strong or weak. 119 A strong recommendation is given when an intervention is clearly beneficial or detrimental to the patient. A weak recommendation is attributed in situations where the beneficial aspects of the intervention must be weighed against the patient’s individual circumstances and preferences.…”

Section: Limitations Of the Grade Systemmentioning

confidence: 99%

Guideline Development for Medical Device Technology: Issues for Consideration

Battelino

Brosius

Ceriello

et al. 2022

J Diabetes Sci Technol

View full text Add to dashboard Cite

Advances in the development of innovative medical devices and telehealth technologies create the potential to improve the quality and efficiency of diabetes care through collecting, aggregating, and interpreting relevant health data in ways that facilitate more informed decisions among all stakeholder groups. Although many medical societies publish guidelines for utilizing these technologies in clinical practice, we believe that the methodologies used for the selection and grading of the evidence should be revised. In this article, we discuss the strengths and limitations of the various types of research commonly used for evidence selection and grading and present recommendations for modifying the process to more effectively address the rapid pace of device and technology innovation and new product development.

show abstract

BMJ Rapid Recommendations: A Possible Revolution in Clinical Practice Guidelines

Abstract: BMJ rapid recommendations hold the potential to revolutionize clinical practice guidelines, achieving both timeliness, trustworthiness, and usefulness to clinicians and patients to allow well informed decisions in clinical practice.

Cited by 10 publications

References 25 publications

The guideline for therapeutic drug monitoring guidelines development

The guideline for therapeutic drug monitoring guidelines development

Protocol for EHS Rapid Guideline: Systematic Review, Meta-Analysis, GRADE Assessment, and European Recommendations on Parastomal Hernia Prevention

Guideline Development for Medical Device Technology: Issues for Consideration

Contact Info

Product

Resources

About